A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can Be Treated With a Group of Medications Known as Bisphosphonates.

Trial Profile

A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can Be Treated With a Group of Medications Known as Bisphosphonates.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Apr 2012

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Cancer metastases; Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 27 Apr 2012 Location (Hungary) added as reported by ClinicalTrials.gov.
    • 27 Apr 2012 Actual end date (Apr 2005) added as reported by ClinicalTrials.gov.
    • 27 Apr 2012 Actual patient number is 43 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top